Committed to sharing our science

Committed to sharing our science

357 results available

A Multicenter, Double-blind, Randomized, Placebo-controlled Trial to Assess Efficacy and Safety of Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure with Severely Reduced Ejection Fraction

Poster, HFSA 2025

Felker, GM et al.

September 28, 2025
Safety and Efficacy of Aficamten in Patients with Nonobstructive Hypertrophic Cardiomyopathy: A 96-week Analysis From FOREST-HCM

Oral Presentation, HFSA 2025

Masri, A et al.

September 28, 2025
Divergent Effect of Aficamten Versus Metoprolol on Exercise Performance in Obstructive Hypertrophic Cardiomyopathy: A Prespecified Analysis of MAPLE-HCM

Oral Presentation, HFSA 2025

Lewis, GD et al.

September 28, 2025
Effect of Aficamten Compared with Metoprolol on Echocardiographic Measures in Symptomatic Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM

Journal of the American College of Cardiology

Hegde, SM et al.

August 31, 2025
Effect of Aficamten Compared with Metoprolol on Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Prespecified Analysis of MAPLE-HCM

Oral Presentation, ESC 2025

Hegde, SM et al.

August 31, 2025